They ameliorate the T cell dysfunction through the double roles of loaded JQ1, which simultaneously decreases the expression of PD‐1 and TIM‐3 on T cells, and the expression of PD‐L1 on tumor cells. This evidence concerns the gene HAVCR2 and neoplasm.